By Dawood Fakhir (September 23, 2024, 4:45 PM BST) — German biotech company Pentixapharm said Monday that it is set to launch an initial public offering valued at approximately €23.4 million ($26 million) on the Frankfurt stock exchange on Tuesday at a valuation of up to €132.7 million….
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+…
